Home Business Corona vaccine CVnCoV Bad interim result for CureVac Setback for CureVac: The...

Corona vaccine CVnCoV Bad interim result for CureVac Setback for CureVac: The corona vaccine CVnCoV only showed an effectiveness of 47 percent in the second interim analysis, said the Tübingen-based company. The study is to be continued.

0
0

Corona vaccine CVnCoV Bad Intermediate result for CureVac

As of: 06/17/2021 6:42 a.m.

Setback for CureVac: The corona vaccine CVnCoV only showed an effectiveness of 47 percent in the second interim analysis, said the Tübingen-based company. The study is to be continued. CureVac’s corona vaccine candidate CVnCoV missed the statistical targets in a second interim analysis. The Tübingen-based company announced this in a mandatory notification. There it says: “In a previously unprecedented environment with at least 13 variants within the subset of study participants examined in this interim analysis, CVnCoV achieved a preliminary effectiveness of 47 percent against COVID-19 disease of any severity and thus did not meet the specified statistical success criteria.” Initial analyzes have shown that the effectiveness depends on the age group examined and the virus strains, the company continues. The vaccine candidate is in the final stage of clinical development. CEO Franz-Werner Haas announced that one had hoped for stronger results in the interim analysis. But continue the current study until the final analysis.

06/17/2021

CureVac vaccine not very effective Crash of a Bearer of hope

The CureVac crash hits countless private investors, taxpayers and the German vaccination campaign.

Actually soon approval is planned

Until the beginning of June it had been said that the company expected – depending on the clinical trial data – the approval of its vaccine candidate in the EU at least for the second quarter. But shortly afterwards it became known that the proceedings would be further delayed.

CureVac, which works with Bayer, had long been considered one of the hopes in the competitive race for approval of the first corona vaccines. But while vaccines have been administered by numerous competitors worldwide for months, the Tübingen-based company is still collecting data – and recently had repeatedly put off shareholders and observers.

background June 15, 2021

Current numbers Corona vaccinations in Germany

How many people in Germany have been vaccinated against Corona once or completely?